Table 2.
Variables |
Syndecan-1 |
P | |
- | + | ||
Serum AFP level | |||
≤25 ng/mL (n = 22) | 8 | 14 | 0.28 |
>25 ng/mL (n = 29) | 15 | 14 | |
HBsAg | |||
Positive (n = 16) | 6 | 10 | 0.465 |
Negative (n = 35) | 17 | 18 | |
Microsatellite nodule | |||
Absent (n = 31) | 13 | 18 | 0.578 |
Present (n = 20) | 10 | 10 | |
Tumor size | |||
≤3 cm (n = 18) | 9 | 9 | 0.607 |
>3 cm (n = 33) | 14 | 19 | |
Cirrhosis | |||
Absent (n = 36) | 17 | 19 | 0.64 |
Present (n = 15) | 6 | 9 | |
Necrosis | |||
Absent (n = 24) | 10 | 14 | 0.646 |
Present (n = 27) | 13 | 14 | |
Portal vein thrombosis | |||
Absent (n = 37) | 15 | 22 | 0.292 |
Present (n = 14) | 8 | 6 | |
Differentiation | |||
Well (n = 35) | 10 | 25 | 0.001 |
Low (n = 16) | 13 | 3 | |
Extra-hepatic metastasis | |||
Absent (n = 41) | 15 | 26 | 0.014 |
Present (n = 10) | 8 | 2 |